Newsbrief: States ‘frustrated’ by lack of rescheduling guidance, report

Cannabis regulators and officials in several states expressed impatience with the Trump administration over its lack of guidance on what rescheduling MED means for their licensed markets. The feds have not updated them on issues such as registering with the DEA, exposure to industry-hated federal tax rule 280E, and any potential compliance requirements according to a report in Stateline.

“None of us really can effectively advise our licensees, which . . .